XTLBNasdaqPharmaceutical Preparations
XTL BIOPHARMACEUTICALS LTD
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026
$1.96−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$1.69MFY2025